To the Editor We read with interest the article by Lazarus et al,1 demonstrating an association between the use of proton pomp inhibitors (PPIs) and elevated risk of incident chronic kidney disease (CKD).1 We hypothesize that, besides recurrent acute kidney injury and hypomagnesemia, altered gut microbial composition and metabolism may be in the causal pathway between PPIs and CKD.